Zevra Therapeutics (ZVRA) EBIT (2014 - 2026)
Zevra Therapeutics' EBIT came in at $16.78 million for Q2 2026, compared with -$71.04 million a year earlier and down 67.8% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) EBIT (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Zevra Therapeutics reported EBIT of $82.38 million; for FY2025, it was -$62.94 million.
- Going back by year, EBIT was -$87 million in FY2024, -$49.6 million in FY2023, -$42.57 million in FY2022 and $7.73 million in FY2021.
- The five-year range for quarterly EBIT is -$71.04 million (Q2 2025) to $52.15 million (Q1 2026).
- Business Quant data shows ZVRA's EBIT at $52.15 million (Q1 2026), $9.32 million (Q4 2025) and $4.14 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Zevra Therapeutics | 612.56 Mn | -200.15 Mn | 38.18 Mn | 16.78 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.78 Mn |
| Mar 31, 2026 | 52.15 Mn |
| Dec 31, 2025 | 9.32 Mn |
| Sep 30, 2025 | 4.14 Mn |
| Jun 30, 2025 | -71.04 Mn |
| Mar 31, 2025 | -5.36 Mn |
| Dec 31, 2024 | -15.42 Mn |
| Sep 30, 2024 | -27.31 Mn |
| Jun 30, 2024 | -23.80 Mn |
| Mar 31, 2024 | -20.49 Mn |
| Dec 31, 2023 | -15.16 Mn |
| Sep 30, 2023 | -15.36 Mn |
| Jun 30, 2023 | -6.25 Mn |
| Mar 31, 2023 | -12.83 Mn |
| Dec 31, 2022 | -9.31 Mn |
| Sep 30, 2022 | -6.63 Mn |
| Jun 30, 2022 | -24.77 Mn |
| Mar 31, 2022 | -1.86 Mn |
| Dec 31, 2021 | -2.84 Mn |
| Sep 30, 2021 | -2.22 Mn |
API Access
Zevra Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();